CooperVision’s MyDays Energys contact lenses hit US market

Article

First 1-Day Lens that combines DigitalBoost and Aquaform technologies designed to deliver comfort for ‘always on’ digital lifestyles

Photo courtesy of © BullRun

Photo courtesy of © BullRun

On March 1, 2023, CooperVision announced that MyDay Energys, the latest addition to the MyDay contact lens line, is now available to eye care practitioners across the United States.1 This is the global debut of the lenses, which are designed to address symptoms of digital eye strain.

MyDay Energys is the first and only 1-day contact lens that combines CooperVision’s aspheric design and material technology to help tiredness and dryness associated with digital eye strain.2 The single vision aspheric design delivers a +0.3D boost of power, aimed to ease strain on eye muscles allowing the wearer to shift focus from on screen to off screen with less effort.3 CooperVision also incorporated its Aquaform Technology, which hydrates MyDay Energys lenses to twice their weight in water4 for natural wettability and comfort, helping eyes feel less dry.

Around 75% of patients from a clinical study said their eyes stay comfortable and relaxed throughout the day—despite frequently viewing digital devices2—while wearing MyDay Energys. Additionally, 80% of wearers said they had less eye fatigue when wearing MyDay Energys, 74% of patients said their vision was less blurry.1

“The average American now spends more than seven hours per day looking at screens,4 with more than half using two or more devices simultaneously.5 Our ability to anticipate this evolution of digital usage and increase in 1-day preference allowed us to be first to market with such an inventive lens,” Michele Andrews, OD, vice president of professional and government affairs, in the Americas at CooperVision, said in a press release.1 “Based on enthusiastic feedback from trial customers, we expect U.S. eye care professionals and contact-lens wearers to widely embrace MyDay Energys.”

MyDay Energys lenses are part of CooperVision’s plastic neutrality initiative, in partnership with Plastic Bank, which recovers plastic from oceans across the globe. To date, the partnership has created an environmental impact equivalent to 130.5 million plastic bottles recovered from oceans.5

For more information, visit the MyDay Energys practitioner page.

References
  1. CooperVision’s Latest Innovation, MyDay Energys® Contact Lenses, Make U.S. Debut. CooperVision. Accessed March 1, 2023. https://coopervision.com/our-company/news-center/press-release/coopervision-latest-innovation-myday-energys-contact-lenses
  2. ‌CVI data on file 2018. Prospective, multi-center (5 US sites), open label, bilateral wear, one week dispensing study with MyDay Energys. N=77 habitual soft CL wearers. Patients slightly agree/agree/strongly agree.
  3. Kajita M et al. Changes in accommodative micro-fluctuations after wearing contact lenses of different optical designs. Cont Lens Ant Eye (2020) In Press https://doi.org/10.1016/j.clae.2020.03.003
  4. Digital 2023: The United States of America. Datareportal. Consumption of different digital media types may occur concurrently.  https://datareportal.com/reports/digital-2023-united-states-of-america. Accessed 9 February 2023.
  5. CooperVision. CooperVision. Accessed March 1, 2023. https://sustainability.coopervision.com/?_ga=2.25408639.351389498.1677689743-1747875558.1677689743
Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.